Proceedings of International Conference on Applied Innovation in IT  ·  2026/03/31  ·  Vol. 14  ·  Issue 1  ·  pp. 843–848
Data-Driven Analysis of Hematological and Biochemical Changes in Non-Insulin-Dependent Diabetes Patients
Bashaer Abbuod Musawi
📄 Download PDF DOI: 10.25673/123645
Abstract
Non-insulin-dependent diabetes mellitus (NIDDM) is associated with metabolic and hematological changes that may lead to complications. To study the physiological and biochemical blood parameters in male NIDDM patients in Najaf, Iraq. 40 male patients with NIDDM, aged 38–70 years, were examined over a three-month period after confirmation of NIDDM. Physiological parameters included hemoglobin concentration, total and differential white blood cell count, and erythrocyte sedimentation rate (ESR). Biochemical parameters included serum glucose and total cholesterol. We compared them with 40 healthy males. Data are presented as mean ± standard error, and significance was tested at p<0.05. Patients showed a significant increase (p<0.01) in total white blood cell count and erythrocyte sedimentation rate compared to the control group. Serum glucose and total cholesterol levels also increased significantly (p<0.01). No significant changes were observed in hemoglobin concentration and some white blood cell subsets. Differential counts revealed neutrophilia and a relative decrease in lymphocytes in the patients. The Iraqi patients who have non-type 2 diabetes show significant changes in biochemical parameters, and hematological, particularly hyperglycemia, dyslipidemia, and inflammation.
Keywords
Non-Insulin-Dependent Diabetes Mellitus Hematologsy Serum Glucose Cholessterol Iraq Inflammation.
References
  1. W. K. Al-Delaimy et al., “Inflammation markers and type 2 diabetes: A review,” Diabetes Care, vol. 42, no. 6, pp. 1075-1082, 2019.
  2. A. A. Al-Kaisy et al., “Epidemiology of type 2 diabetes mellitus in Iraq: A cross-sectional study,” Iraqi Journal of Medical Sciences, vol. 19, no. 4, pp. 455-462, 2021.
  3. American Diabetes Association, “Standards of medical care in diabetes-2023,” Diabetes Care, vol. 46, suppl. 1, pp. S1-S154, 2023.
  4. M. Y. Donath and C. A. Dinarello, “Immunologic and inflammatory mechanisms in type 2 diabetes,” Nature Reviews Immunology, vol. 19, no. 10, pp. 594-606, 2019.
  5. D. Huang et al., “Dyslipidemia and cardiovascular risk in patients with type 2 diabetes,” Frontiers in Endocrinology, vol. 11, p. 602, 2020.
  6. International Diabetes Federation, IDF Diabetes Atlas, 10th ed., Brussels, Belgium, 2023.
  7. M. Jaiswal et al., “Cardiovascular risk factors in youth with type 1 and type 2 diabetes: Insights from the SEARCH study,” Diabetes Care, vol. 43, no. 11, pp. 2678-2686, 2020.
  8. A. K. T. Al-Attaby and M. Q. D. Al-Lami, “Effects of duration and complications of type 2 diabetes mellitus on diabetic related parameters, adipocytokines and calcium regulating hormones,” Iraqi Journal of Science, vol. 60, no. 11, 2019, [Online]. Available: https://doi.org/10.24996/ijs.2019.60.11.5.
  9. A. Arnaoty, I. I. Shahad, D. Suhail, S. A. K. Mohammed, and J. M. J. Al Saffar, “A group of Iraqi patients with type II diabetes mellitus have a correlation between HbA1c, lipids, and thyroid hormone,” Indian Journal of Forensic Medicine & Toxicology, vol. 17, no. 1, pp. 76-81, 2022, [Online]. Available: https://doi.org/10.37506/ijfmt.v17i1.18898.
  10. E. S. Al-Fatlawey, “Investigation of vitamin D levels in Iraqi patients with Type 2 diabetes mellitus: A case-control study,” Texas Journal of Medical Science, vol. 27, pp. 10-16, 2023, [Online]. Available: https://doi.org/10.62480/tjms.2023.vol27.pp10-16.
  11. Z. A. Rashid, A. A. Naji, and Z. H. Ismaeel, “Barriers to blood glucose control in type 2 diabetic patients with poor glycemic control in Kirkuk City/Iraq,” Iraqi Journal of Medical Sciences, vol. 21, no. 1, pp. 11-22, 2023, [Online]. Available: https://doi.org/10.22578/IJMS.21.1.2.
  12. W. M. Ali, B. J. Kamal, and K. S. Ahmed, “Metabolic syndrome as a predictor of incident type 2 diabetes and cardiovascular events in the Kirkuk population: A prospective cohort study,” The Review of Diabetic Studies, 2024, [Online]. Available: https://doi.org/10.1900/9k2hdt09.
  13. A. A. Mansour et al., “Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: A retrospective analysis of a tertiary care database over a 9-year period,” Diabetes & Metabolic Syndrome: Clinical Research & Reviews, vol. 14, no. 3, pp. 265-272, 2020.
  14. Z. S. Ramzi and M. A. Sulaiman, “Microalbuminuria in patients with diabetes mellitus: Prevalence and associated risk factors,” Kurdistan Journal of Applied Research, vol. 2, no. 23, 2017, [Online]. Available: https://doi.org/10.24017/science.2017.2.23.
  15. J. C. Pickup, “Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes,” Diabetes Care, vol. 43, no. 7, pp. 1473-1481, 2020.
  16. Y. Wang et al., “Leukocyte counts and risk of complications in type 2 diabetes,” BMC Endocrine Disorders, vol. 22, p. 89, 2022.
  17. S. E. Shoelson, J. Lee, and A. B. Goldfine, “Inflammation and insulin resistance,” The Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793-1801, 2006.
  18. T. Zhu et al., “Hematological indices as predictors of inflammation in diabetes,” Journal of Clinical Laboratory Analysis, vol. 35, no. 3, p. e23673, 2021.
  19. American Diabetes Association, “Standards of medical care in diabetes-2024,” Diabetes Care, vol. 47, suppl. 1, pp. S1-S321, 2024, [Online]. Available: https://doi.org/10.2337/dc24-SINT.
  20. M. J. Fowler, “Microvascular and macrovascular complications of diabetes,” Clinical Diabetes, vol. 26, no. 2, pp. 77-82, 2008, [Online]. Available: https://doi.org/10.2337/diaclin.26.2.77.
  21. J. M. Forbes and M. E. Cooper, “Mechanisms of diabetic complications,” Physiological Reviews, vol. 93, no. 1, pp. 137-188, 2013, [Online]. Available: https://doi.org/10.1152/physrev.00045.2011.
  22. A. J. M. Boulton et al., “Diabetic neuropathies: A statement by the American Diabetes Association,” Diabetes Care, vol. 28, no. 4, pp. 956-962, 2005, [Online]. Available: https://doi.org/10.2337/diacare.28.4.956.

Proceedings of the International Conference on Applied Innovations in IT by Anhalt University of Applied Sciences is licensed under CC BY-SA 4.0  ·  This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License

ICAIIT 2026
International Conference on Applied Innovation in IT
Navigation
Publisher
ISSN2199-8876
Publisher Edition Hochschule Anhalt
Location Anhalt University of Applied Sciences
Email leiterin.hsb@hs-anhalt.de
Phone +49 (0) 3496 67 5611
Address Building 01, Room 425
Bernburger Str. 55
D-06366 Köthen, Germany
Open Access License
CC BY-SA 4.0

All works are licensed under the Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), unless otherwise noted.

Published by ICAIIT in cooperation with Anhalt University of Applied Sciences.

© 2026 ICAIIT — International Conference on Applied Innovations in IT. Anhalt University of Applied Sciences, Köthen, Germany.
Visitors: site traffic counter